Physician profile
Eva M Ross
NPI 1629372495
$634.22
in general payments reported to CMS, 2019-2025
10 companies · $111 in 2025
The $111 reported for 2025 was more than what 76% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.19 · 2022: $104 · 2023: $184 · 2024: $197 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $491.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $237.67 | 2021-2025 | Gentlecath |
| Janssen Biotech, INC. | $71.09 | 2023-2025 | Erleada |
| Abbvie INC. | $69.75 | 2022-2024 | |
| Medtronic, INC. | $69.45 | 2022-2023 | Interstim |
| Urogen Pharma, INC. | $46.20 | 2024 | |
| Bioprotect Medical, INC. | $41.92 | 2025 | Bioprotect Balloon Implant System |
| Boston Scientific Corporation | $33.70 | 2023 | Spaceoar Vue System - 10ml |
| Merck Sharp & Dohme LLC | $27.51 | 2024 | Lynparza |
| Procept Biorobotics Corporation | $23.76 | 2024 | Aquabeam System |
| Astellas Pharma US INC | $13.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eva Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.